Kaplan-Meier estimates of the disease free survival (DFS) of GEO patients using the 24-lncRNA signature, stratified by TNM stage. Entire GSE62254 set (N = 300) were first stratified by low TNM stage (I & II) and high TNM stage (III & IV). Kaplan-Meier plots were then used to visualize the survival probabilities for the high-risk versus low-risk group of patients determined on the basis of the median risk score from the GSE62254 set patients. (A) Kaplan-Meier curves for the entire GSE62254 set patients (N = 300); (B) Kaplan-Meier curves for patients with low TNM stage (N = 127); (C) Kaplan-Meier curves for patients with high TNM stage (N = 173). The tick marks on the Kaplan-Meier curves represent the censored subjects. The differences between the two curves were determined by the two-sided log-rank test. (EPS 1031 kb
